Austin Doyle
Impact in
- Ophthalmology top 2%
- Ocular Oncology and Treatments
- Oncology top 5%
- Lung Cancer Research Studies
Papers in
-
- Multiple Myeloma Research and Treatments 3
- Oncology 7
- Lung Cancer Research Studies 2
- Co-authors
- Adi F. Gazdar (2 shared papers)Ilona R. Linnoila (1 shared paper)SE Martin (1 shared paper)Frank F. Cuttitta (1 shared paper)P A Bunn (1 shared paper)James L. Mulshine (2 shared papers)Keiko Funa (1 shared paper)D Carney (1 shared paper)
- Journals
- Clinical Cancer Research (4 papers)Annals of Oncology (3 papers)Blood (3 papers)Neuro-Oncology (2 papers)Investigational New Drugs (2 papers)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Austin Doyle
30 papers receiving 1.6k citations
Austin Doyle's Hit Papers
Peers
Comparison fields: 5 of 72
- Ophthalmology 239
- Oncology 577
- Immunology 287
- Cancer Research 165
- Pulmonary and Respiratory Medicine 340
Countries citing papers authored by Austin Doyle
This map shows the geographic impact of Austin Doyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Austin Doyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Austin Doyle more than expected).
Fields of papers citing papers by Austin Doyle
This network shows the impact of papers produced by Austin Doyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Austin Doyle. The network helps show where Austin Doyle may publish in the future.
Co-authors
The 25 scholars most cited alongside Austin Doyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma Hit paper breakdown → | 2014 | 356 |
| 2 | 1985 | 352 | |
| 3 | 2015 | 195 | |
| 4 | 2004 | 123 | |
| 5 | 2015 | 68 | |
| 6 | 2006 | 67 | |
| 7 | 2016 | 65 | |
| 8 | 2015 | 47 | |
| 9 | 2019 | 47 | |
| 10 | 2015 | 44 | |
| 11 | 2011 | 43 | |
| 12 | 2011 | 37 | |
| 13 | 2007 | 36 | |
| 14 | 2013 | 32 | |
| 15 | 2010 | 26 | |
| 16 | 1986 | 20 | |
| 17 | 2001 | 17 | |
| 18 | 2016 | 11 | |
| 19 | 2010 | 10 | |
| 20 | 2018 | 9 |
About Austin Doyle
Austin Doyle is a scholar working on Hematology, Oncology, Genetics, Ophthalmology and Neurology, having authored 30 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (3 papers), Protein Degradation and Inhibitors (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Multiple Myeloma Research and Treatments (3 papers), Ocular Oncology and Treatments (3 papers), Glycosylation and Glycoproteins Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Ophthalmology (239 citations), Oncology (577 citations), Immunology (287 citations), Cancer Research (165 citations) and Pulmonary and Respiratory Medicine (340 citations). Austin Doyle has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include Adi F. Gazdar, Ilona R. Linnoila, SE Martin, Frank F. Cuttitta, P A Bunn, James L. Mulshine, Keiko Funa, D Carney, Martin Wj and Mohan Suntharalingam. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Blood, Neuro-Oncology and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.